An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer

Watch this Webcast and download the slides from a CCO symposium at ASCO 2019 to get up to date on how experts are managing patients with HR-positive HER2-negative MBC in the context of an evolving treatment paradigm.

Share

Program Content

No activities added yet

No activities added yet

Supporters

This activity is supported by independent educational grants from

Lilly

Novartis Pharmaceuticals Corporation